LOXL2 and neoplasm: The correlation between LOXL2-positive expression and clinicopathological characteristics of patients was analyzed as shown in Table 2, and LOXL2-positive expression was associated with ESCC T stage (p = 0.003) and lymphatic metastasis (p = 0.010), but no differences were observed in patient age, sex, CEA expression status or tumor.